Whereas recombinant Schistosoma TSP2 is a potential vaccine candidate against schistosomiasis (Mekonnen et al., 2020), initial vaccine studies with complete adult worm EVs showed no clear protection thus far (Kifle, 2020). Here, THBS2 is linked to schistosomiasis.